Lecturers to be consulted on industrial action following ‘derisory' pay offer
The ballot will be open for six weeks and will close on August 11.
The EIS ULA, which is open to all university lecturers in Scotland, has called on its members to reject what it called a 'real-terms pay cut' and back industrial action.
It said the offer 'fails to recognise' the contribution made by university lecturers, or make up for years of below-inflation pay rises.
It also called on employers to return to the negotiating table with a 'significantly improved' offer, warning of 'widespread disruption' if industrial action were to take place.
Garry Ross, EIS ULA national officer, said: 'This 1.4% offer is not just disappointing, it is derisory and does not reflect the dedication and expertise of our university lecturers and academic-related members.
'Our members are working harder than ever, delivering world-class education and research, yet their financial security continues to be undermined by employers who appear unwilling to offer a fair deal.
'This offer fails to recognise the essential contributions of our members and does nothing to address the severe impact of rising living costs or the sub-inflationary rises they have experienced over a number of years.'
The union said the offer stood in 'stark contrast' to the 4.14% increase given to further education lecturers, and to pay awards made to NHS workers and other public sector employees across Scotland.
It said this disparity highlighted a 'clear injustice' within higher education, and demonstrated the need for a more equitable approach to staff pay,
A Scottish Government spokesperson said: 'Staffing and operational matters are the responsibility of individual universities.
'The Scottish Government is not directly involved in higher education pay negotiations, but we are absolutely clear that Fair Work must be the guiding principle for all employment-related decisions, and we continue to urge university management and the respective trade unions to reach decisions that ensure employees are treated fairly.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
an hour ago
- Telegraph
NHS will have to pay more for British doctors, Streeting is warned
Wes Streeting's plan to prioritise British doctors for NHS jobs risks piling more pressure on the public finances by driving up wages, analysts have warned. Economists at the Institute For Public Policy Research (IPPR), a Left-leaning think tank, said proposals by the Health Secretary to ensure medics who train in Britain are first in the queue for NHS roles will embolden staff to ask for higher pay. The commitment to hire no more than one in 10 doctors from overseas is part of Labour's 10-year plan to revive the health service as waiting lists remain above 7m. However the long awaited proposals – published this week – also come as doctors threaten strike action over a 'derisory' 4pc pay rise and junior doctors demand much higher increase. Seb Rees, at the IPPR, said that while Mr Streeting was 'right to want to train more homegrown doctors and reduce the NHS's reliance on overseas recruitment', it risked pushing up staffing costs. He said: 'The wider impact on pay is unclear, but greater reliance on domestic graduates could put upward pressure on wages. Unlike overseas staff, UK-trained doctors may be more likely to push for higher settlements over time.' Mr Rees added that the Government's ambition to reduce reliance on new overseas recruits from a quarter to one in 10 would be met by the reality of an ageing population that would increase demand for NHS services. 'The UK taxpayer makes a major investment in medical training, and it's simply not acceptable that many British doctors finish their training only to find there's no job waiting for them,' he said. 'However, the Government must be realistic about the scale of the challenge. Today, around two thirds of newly registered doctors are international medical graduates. 'Rebalancing this will require sustained investment in our training pipeline. With an ageing population and rising demand, we will need a larger medical workforce overall – and international recruitment has often been the fastest and most cost-effective way to meet that need. NHS has become 'over-reliant' on foreign workers Writing on social media site X, Mr Streeting vowed to revamp the NHS workforce. He said: 'I'm proud that the NHS has always been open to international talent, but the truth is that we've become over-reliant – including on countries with severe shortages of healthcare staff. 'We'll going to do more to grow our own and retain on talent.' The NHS is one of the world's biggest employers, directly employing 1.7m people in England. Health spending is by far the largest in Whitehall, with a day-to-day budget of roughly £200bn, half of which is spent on staffing costs. Other analysts highlighted that Mr Streeting's plans largely mirrored that of the previous government's proposals, which expected 'around 9pc to 10.5pc of our workforce to be recruited from overseas'. Max Warner, at the Institute for Fiscal Studies, a think tank, said: 'The NHS workforce is almost certainly going to have to grow in the coming years and decades to meet growing demand. Provided there is sufficient domestic supply of healthcare staff, this announcement doesn't necessarily affect the total number of staff working in the NHS. 'If this domestic supply is insufficient, then this could either mean we rely more on international recruitment or grow the NHS workforce at a slower rate.'
The Guardian
an hour ago
- The Guardian
AstraZeneca boss ‘wants to shift stock market listing to US'
AstraZeneca's chief executive Pascal Soriot has reportedly said that he would like to shift the company's stock market listing from the UK to the US. The boss of Britain's most valuable listed company has spoken privately about a preference to move the listing to New York, the Times reported. It added that he had also considered moving the company's domicile. The FTSE 100 company's share price rose by 2.8% on Tuesday, with most of the increase happening after the story was published. A shift in AstraZeneca's listing would deal a major blow to the London Stock Exchange, which has already had to deal with a series of departures by companies seeking higher valuations. Among those who have left the FTSE 100 in recent years are equipment rental company Ashtead, Paddy Power bookmaker owner Flutter Entertainment, building materials supplier CRH and packaging company Smurfit Westrock. A shift by AstraZeneca would almost certainly face opposition by the UK government, although it would not have the power to formally block a move. Labour made life sciences one of its key growth sectors in its industrial strategy published last month. A spokesperson for AstraZeneca declined to comment. AstraZeneca is thought to have expressed frustrations privately with the rejection of its breast cancer drug, Enhertu, by the NHS on cost grounds. Earlier this year, the company, headquartered in Cambridge, caused consternation in government by pulling out of a £450m project to produce vaccines in Speke, Liverpool, while saying that the business case did not make sense without more financial support from government. Soriot has overseen the market value of AstraZeneca more than tripling since he took over in October 2012. The company has overtaken oil company Shell – also seen as a contender for a move to the US – and HSBC, a bank, with a market value of £157bn. The US is the world's biggest pharmaceutical market, with by far the highest spending per person on medicines despite having a lower life expectancy than several other countries. UK executives have long complained that their companies are undervalued compared with American counterparts. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion Soriot has emphasised the company's ambitions to grow in the US. In November, he told investors that 'we want to see even more growth in the US over the next few years as part of our 2030 ambition,' according to a transcript from data company Alphasense. The 'US is, of course, a very important market and that supports innovation, and we will continue to invest to grow fast in this part of the world,' Soriot said. The chief executive's pay has increased in line with AstraZeneca's market value. He has been the highest-paid chief executive on the FTSE 100 for two years running, receiving £16.85m for 2023, up from £15.3m in 2022.
Glasgow Times
an hour ago
- Glasgow Times
This check will happen before Glasgow Clyde Tunnel toll charge
The local authority has expressed interest in rolling out driver charges that would only apply to people who don't live in the city. But a regulatory check is to be carried out before councils can introduce the system – and that is not likely to happen until after next year's Scottish Parliament elections in May, a meeting heard. Councillor Angus Millar told last week's full council meeting: 'The council has no specific proposals to introduce any road user charging in Glasgow. However members will be aware that the council has repeatedly stated its interest in further exploring possibilities around a boundary congestion charge and potential tolling at the Clyde Tunnel – both with exemptions for Glasgow residents.' The convenor for climate, Glasgow Green Deal, transport and city centre recovery added: 'Council officers continue to engage with Transport Scotland and Cosla particularly in relation to national commitments to reduce car vehicle mileage and the potential roll out of road user charging as a travel demand management tool. 'Transport Scotland has expressed interest in Glasgow and Edinburgh taking a lead role in exploring road user charging and we anticipate further discussions with City of Edinburgh Council in establishing their interest.' Explaining how legal details are to be firmed up, the SNP councillor said: 'We welcome the recent commitment from Transport Scotland and the Scottish Government to undertake legislative and regulatory review to establish how the process can be clarified for local authorities to take forward and this is a matter I have engaged with officials and other councils on via COSLA.' He added: 'We will engage in the coming legislative review to ensure Glasgow is well positioned to consider any developments.' His comments came after Scottish Green councillor Blair Anderson asked for an 'update on proposals for road user charging in the city following the Scottish Government's recent commitment to empower councils to introduce schemes.' Welcoming the continued interest in the scheme, Councillor Anderson said the 'only way we can meet our climate targets is moving people from cars to public transport.' He added: 'A road user charging scheme would give us the money to make Glasgow's buses publicly owned, reliable, fast and free.'
